SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-13-000051
Filing Date
2013-11-13
Accepted
2013-11-13 17:04:41
Documents
3
Period of Report
2013-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kpressrelease3q2013.htm 8-K 29241
2 EXHIBIT exhibit9913q2013.htm EX-99.1 115666
3 GRAPHIC oceraingrayandorangewitha03.jpg GRAPHIC 23227
  Complete submission text file 0001274644-13-000051.txt   178321
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 131215483
SIC: 2834 Pharmaceutical Preparations